Nabors Industries <NBR.N>: Barclays cuts target price to $93 from $99
NBR•Related News
Spyre Therapeutics Inc <SYRE.O>: Leerink Partners Raises Target Price to $124 From $106
SYRE•
Dynatrace Q1 revenue slightly beats estimates on new customer growth
DT•
CVS climbs after raising annual profit forecast
CVS•
Capri Q1 FY27 EPS rises to $0.60; revenue drops 3.5% to $769 million
CPRI•
CMC targets FY29 core EBITDA of $1.65 billion-$1.8 billion
CMC•